Compounded tirzepatide
Sold by Pallas Health · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$179
| Medication · First month | $179 |
|---|---|
| Consultation fee · first month only | $0 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| First monthAdvertised “Compounded Tirzepatide $179 first month · then $299/mo avg” | Per month$179 | Charged today$179 |
| Every 12 weeks “Compounded tirzepatide: $179 for your first month, then $897 every 12 weeks ($299/mo average).” | Per month$299 | Charged today$897 |
This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.
History
- September 2, 2026 — $179
- September 2, 2026 — $179
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | All 50 states |
| Prescriber | Both |
| Cancellation | “Cancel anytime.” |
| Membership | Not disclosed |
| Consult fee | $0. Pallas says “Compounded plan prices include provider care, ongoing check-ins, and care-team messaging — no separate membership fee.” No separate consultation charge is named. |
Recorded from pallashealth.co. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — After the first month, Pallas bills $897 every 12 weeks. The advertised $299 is its average across those 12 weeks, not what any single month costs.
- 2. September 2, 2026 — The same page sells four brand drugs for cash: Wegovy and Mounjaro at $1,349 a month, Ozempic at $1,299 and Zepbound at $1,069.
2 further notes concern other Pallas Health programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.